RegentAtlantic Capital’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
$369K Sell
2,009
-299
-13% -$59.6K 0.01% 525
2022
Q2
$388K Sell
2,308
-454
-16% -$97.5K 0.01% 491
2022
Q1
$692K Buy
2,762
+576
+26% +$145K 0.02% 387
2021
Q4
$562K Buy
2,186
+188
+9% +$46K 0.02% 429
2021
Q3
$485K Buy
1,998
+962
+93% +$235K 0.01% 440
2021
Q2
$214K Buy
+1,036
New +$211K 0.01% 606

Other funds holding HCA

RegentAtlantic Capital's HCA Position: Q3 2022 in Review

RegentAtlantic Capital reduced its HCA Healthcare (HCA) stake by 13% in Q3 2022, selling an estimated $59.6K and leaving 2,009 shares worth $369K. The position accounts for 0.01% of the portfolio, ranked #525.

RegentAtlantic Capital first reported a position in HCA in Q2 2021 and has held it in 6 quarters since. The position peaked at $692K in Q1 2022. 867 funds tracked by Wall St. Rank hold HCA as of Q3 2022.

  • RegentAtlantic Capital held 2,009 shares of HCA Healthcare worth $369K as of Q3 2022.
  • RegentAtlantic Capital sold 299 HCA Healthcare shares in Q3 2022, an estimated $59.6K.
  • HCA Healthcare made up 0.01% of RegentAtlantic Capital's portfolio in Q3 2022, its #525 holding.
  • RegentAtlantic Capital first reported a position in HCA Healthcare in Q2 2021 and has held it in 6 quarters since.
  • RegentAtlantic Capital's HCA Healthcare position peaked at $692K in Q1 2022.
  • 867 funds tracked by Wall St. Rank held HCA Healthcare as of Q3 2022.

Based on RegentAtlantic Capital's 13F filing for Q3 2022, filed 14 Nov 2022.